Hiring in life sciences? Share your open positions with our professional community. Read more Close

Your cookie settings

This site uses cookies. Some cookies are essential to make the site work and others help us to improve our services. Read more about cookies in our Privacy policy.

Choose your cookie preferences:

Advertisement

Response by Fearon et al to Letter Regarding Article, "Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial".

Created on 04 Aug 2026

Authors

William F Fearon, Kuniaki Takahashi, Kiran K Khush

Published in

Circulation. Volume 154. Issue 5. Pages e187. Aug 04, 2026. Epub Aug 03, 2026.

PMID:
42546106
Bibliographic data and abstract were imported from PubMed on 04 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Sign in to post a review. Add review
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Do you recommend this? Please sign in. Yes No

Recommended

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement